DXC to Exit Russia - Matching Employee Donations at 200%
DXC Technology condemns the unwarranted aggression from the Russian Government that is leading to the death, injury, and displacement of innocent civilians in Ukraine. DXC stands with every person, company, and government across the world that is calling for an immediate end to this unprovoked attack on Ukraine.
Currently, our number one priority is to care for our colleagues in the region. Our dedicated DXC team is working around the clock to provide shelter, financial assistance, health care, and relocation support to our colleagues and their families.
Based on the aggression from the Russian Government, we are no longer pursuing business in Russia and have committed to exit this market. We have approximately 4,000 colleagues in Russia and are supporting them in this time of need. We continue to support and maintain rigorous compliance with all applicable sanctions levied against Russia.
Aligned with our “People-first” strategy, DXC is matching employee donations to the Red Cross humanitarian efforts at 200% which includes providing direct financial support to our impacted colleagues. We are caring for all our people regardless of their nationality or country of origin.
We will continue to assess the situation and take the required measures leveraging the strength of our global team to help minimize any impact on our DXC colleagues and customers.
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services across the Enterprise Technology Stack to drive new levels of performance, competitiveness, and customer experience. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220304005261/en/
Contact information
Media
Sean B. Pasternak
Corporate Media Relations
1-647-975-7326
Sean.Pasternak@DXC.com
John Sweeney, CFA
Vice President, Investor Relations
+1-980-315-3665
John.Sweeney@DXC.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement20.11.2024 14:05:00 CET | Press Release
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120379204/en/ Bladder cancer remains a significant health challenge worldwide, with over 614,000 new cases and 220,600 deaths recorded in 2022. Novotech’s latest report provides a detailed examination of the evolving landscape in bladder cancer research, with a focus on clinical trial trends, emerging therapeutic strategies, and regional variations in patient outcomes. Key Highlights from the Report: Bladder Cancer Statistics: A thorough analysis of incidence and survival data, highlighting that Europe and
TreviPay Embeds Dynamic Trade Credit Application into B2B Buyer Onboarding Process20.11.2024 14:00:00 CET | Press Release
TreviPay, the most-trusted B2B payments and invoicing network, has expanded its order-to-cash (O2C) offering by enhancing the buyer onboarding experience through automation. With TreviPay’s proprietary Risk Management Platform, business buyers can now apply for trade credit through a dynamic self-serve application, making the onboarding experience easier, faster and more tailored. As the global B2B market continues to grow, sellers can leverage TreviPay’s automation technology to reduce manual reviews while also speeding up credit decisioning to near real-time. The dynamic application is localized for an expanded list of key geographies, including the U.S., Australia, Canada and the UK, to ensure country-specific business terminology, language and foreign regulatory requirements are addressed. As highlighted during the inaugural TreviPay Crossroads conference in October, merchants who optimize the O2C process improve the B2B payments experience and build long-term buyer loyalty. Seamle
Uniphore and Konecta Join Forces to Advance AI in Customer Experience and Digital Transformation20.11.2024 14:00:00 CET | Press Release
Uniphore, a global AI leader with the only end-to-end Enterprise AI architecture that delivers unmatched customer focused solutions, together with Konecta, a global leader in customer experience (CX) and digital services, today announced a strategic alliance that will create and accelerate true AI-powered value worldwide. This is a significant first in the evolution of Enterprise AI with two industry leaders coming together to deliver real ROI through scalable solutions across hundreds of large global customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120819767/en/ Global enterprises will benefit from the combined strengths of Uniphore’s enterprise-grade AI solutions and Konecta’s expertise in business transformation. By merging advanced AI with operational excellence, this collaboration is set to reshape customer service delivery, generating actionable insights that drive real value. Clients can expect improved RO
DentalMonitoring Software Major Update Includes FDA Validated AI-Driven Clinical Indications For Orthodontic Patients20.11.2024 11:20:00 CET | Press Release
DentalMonitoring, the leader in Artificial Intelligence (AI)-powered remote monitoring for orthodontics, has released a major software update introducing features and indications based on the company’s De Novo approval from the U.S. Food and Drug Administration (FDA) in May 2024. Used by orthodontists around the world to optimize clinical care, DentalMonitoring’s remote monitoring solution leverages advanced image processing algorithms to analyze intraoral remote scans during orthodontic treatment. Patients take these scans using the DentalMonitoring app on their smartphone with the ScanBoxpro phone holder. The AI-powered software supports practitioners with clinical indications to remotely detect, track, and monitor orthodontic treatment progress for enhanced real-time decision-making, supporting personalized treatment and optimizing scheduling. This makes treatment more convenient for patients and increases clinical control for providers. This press release features multimedia. View
Pulmonary Hypertension Awareness Month : Two European Studies Highlight the Urgency of Patients and Experts to Improve the Diagnosis and Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease20.11.2024 11:00:00 CET | Press Release
Within the month of awareness of pulmonary hypertension, two studies carried out in Europe have been published, highlighting the urgency of patients and doctors to improve the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease. PH is a condition characterised by elevated blood pressure in the pulmonary arteries (the arteries that carry blood from the heart to the lungs)2, whereas ILD are a group of disorders that cause scarring and inflammation of the lung tissue, leading to reduced lung function and difficulty in oxygen transfer2. When PH develops with ILD, it complicates the disease, making it more severe and harder to manage2. On the one hand, a qualitative research carried out by clinical experts, the Pulmonary Hypertension Association Europe (PHA Europe) and the European Pulmonary Fibrosis Federation (EU-PFF) representatives, ORPHA Strategy Consulting, and Ferrer, a B Corp-certified international pharmaceutical company, has highlighted for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom